This inventor holds 3 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Trinity College Dublin, Duke University, Imperial College Innovations Limited. Active years: 2017-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- County Wicklow, IE (2017)
- Bray, IE (2022 - 2024)
Company Filing History:
2 out of 141 
1 out of 2,084 
1 out of 173 
Years Active: 2017-2024
Title: Innovations and Contributions of Anna-Sophia Kiang
Introduction
Anna-Sophia Kiang is a notable inventor based in Bray, Ireland. She has made significant contributions to the field of biomedical innovations, particularly in the treatment of eye diseases. With a total of 3 patents to her name, her work focuses on advanced therapeutic methods that address critical health issues.
Latest Patents
One of her latest patents is centered on RNAi therapy for the treatment and/or prevention of glaucoma. This invention involves an RNAi-inducing agent that can reduce and/or inhibit the expression of proteins associated with the tight junction complex in Schlemm's canal endothelial cells. This innovative approach aims to prevent and treat glaucoma effectively. Another significant patent involves compositions and methods for treating degenerative retinal conditions. This invention targets inflammatory mediators, particularly components of the NLRP3-inflammasome, to address conditions involving drusen and anaphylatoxin-induced choroidal neovascularization. The patent also outlines methods for determining the risk of developing these diseases.
Career Highlights
Throughout her career, Anna-Sophia Kiang has worked with several esteemed institutions, including Prov Fellows College, Holy Trinity, Queen Elizabeth, and Imperial College Innovations Limited. Her diverse experiences have enriched her expertise and contributed to her innovative work in the field.
Collaborations
Anna-Sophia has collaborated with notable colleagues, including Matthew Campbell and Marian Humphries. These partnerships have fostered a collaborative environment that enhances the development of her groundbreaking inventions.
Conclusion
Anna-Sophia Kiang's contributions to biomedical innovations, particularly in the treatment of eye diseases, highlight her role as a leading inventor in her field. Her patents reflect a commitment to advancing healthcare solutions and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile